Skip to Content

Delstrigo 100 mg / 300 mg / 245 mg film-coated tablets

Licence status
Authorised: 22/11/2018
Active substances
Doravirine, Lamivudine, Tenofovir disoproxil fumarate
Dosage Form
Film-coated tablet
Licence number
EU/1/18/1333/001-002
Licence holder
Merck Sharp & Dohme BV,

Licence information

ATC code
J05AR24 lamivudine, tenofovir disoproxil and doravirine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/11/2018